
    
      Oral Immunotherapy will be administered utilizing a powder derived from boiled peanuts.
      Treatment will begin with an initial escalation day in which dosing is begun at 0.1 mg peanut
      protein and escalated to a final dose of 6 mg peanut protein. Doses are ingested orally.
      Participants will continue daily oral ingestion of doses at home and return for updosing
      every 2 weeks to a final maintenance dose of 300 mg peanut protein. Participants will
      continue daily oral ingestion of the peanut product for a minimum duration of 28 days before
      undergoing exit double blind placebo controlled food challenge. At the conclusion of the
      study, participants will be offered continued maintenance therapy off study in line with
      current specialty standards.
    
  